SCHEMBL23438650

SCHEMBL23438650

c1ccc(-c2ccc(N(c3cccc(-c4cccc5c4oc4ccccc45)c3)c3ccc(-c4ccccc4)c(-c4cccc5c4oc4ccccc45)c3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.50
▸ GGPS1 O95749 1/20 0.41
▸ PRKDC P78527 10/20 0.39
▸ PTGES2 Q9H7Z7 1/20 0.39
▸ CDC14B O60729 2/20 0.35
▸ CDC14A Q9UNH5 2/20 0.35
▸ PRMT5 O14744 1/20 0.34
▸ WDR77 Q9BQA1 1/20 0.34
▸ PIK3CD O00329 3/20 0.33
▸ PIK3CB P42338 3/20 0.33
▸ PIK3CA P42336 2/20 0.32
▸ PIK3CG P48736 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ PDE2A O00408 1/20 0.32
▸ PIK3C2A O00443 1/20 0.32
▸ PIK3R2 O00459 1/20 0.32
▸ PIK3C2B O00750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23438451 0.99 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL23438453 0.98 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17886302 0.97 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17886296 0.97 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17886294 0.96 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17886292 0.96 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL23438817 0.96 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL21588549 0.96 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL21588564 0.95 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17886293 0.95 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163411-A1 COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163411-A1 COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR WEE1, WEE2, ALOX12 ALOX5 41/4885GGPS1 72/4885PRKDC 4163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback